Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957073 · ClinicalTrials.gov registry record · NA
Rheos System for the Treatment of HFpEF Heart Failure
A NA study, sponsored by CVRx.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00957073: Completed NA study, sponsored by CVRx.
NCT00957073 is a NA study that has completed, run by CVRx. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957073, a NA study, has completed, sponsored by CVRx.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.
Primary Outcome
To systematically and actively ascertain the type, frequency, severity and timing of long-term adverse events in subjects implanted with the device.
Interventions
- DEVICE Rheos® system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-08 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
What the finished NCT00957073 record still lists
NCT00957073 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Rheos® system is the first listed.
NCT00957073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00957073 about?
NCT00957073 is a clinical study titled "Rheos System for the Treatment of HFpEF Heart Failure". The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.
What is the current status of trial NCT00957073?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2009-08. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT00957073?
The interventions under investigation include: Rheos® system (DEVICE).
Who is sponsoring clinical trial NCT00957073?
This trial is sponsored by CVRx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00957073's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia